Hemab closes $157m in funding for bleeding disorder treatments

finance.yahoo.com/news/hemab-closes-157m-funding-bleeding-092825950.html

Hemab Therapeutics has concluded an oversubscribed Series C funding round, raising $157m to further develop therapies for bleeding disorders.
The investment round was spearheaded by Sofinnova Partners and saw contributions from a global asset management company.
New investors, along with…

This story appeared on finance.yahoo.com, 2025-10-28 09:28:25.
The Entire Business World on a Single Page. Free to Use →